Overview of Antagonists Used for Determining the Mechanisms of Action Employed by Potential Vasodilators with Their Suggested Signaling Pathways

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2016 Apr 20

PMID 27092479

Citations 5

Authors

Yean Chun Loh

Chu Shan Tan

Yung Sing Chng

Mariam Ahmad

Mohd Zaini Asmawi

Mun Fei Yam

Affiliations

Soon will be listed here.

Abstract

This paper is a review on the types of antagonists and the signaling mechanism pathways that have been used to determine the mechanisms of action employed for vasodilation by test compounds. Thus, we exhaustively reviewed and analyzed reports related to this topic published in PubMed between the years of 2010 till 2015. The aim of this paperis to suggest the most appropriate type of antagonists that correspond to receptors that would be involved during the mechanistic studies, as well as the latest signaling pathways trends that are being studied in order to determine the route(s) that atest compound employs for inducing vasodilation. The methods to perform the mechanism studies were included. Fundamentally, the affinity, specificity and selectivity of the antagonists to their receptors or enzymes were clearly elaborated as well as the solubility and reversibility. All the signaling pathways on the mechanisms of action involved in the vascular tone regulation have been well described in previous review articles. However, the most appropriate antagonists that should be utilized have never been suggested and elaborated before, hence the reason for this review.

Citing Articles

New insights on mode of action of vasorelaxant activity of simvastatin.

Verma K, Shukla R, Dwivedi J, Paliwal S, Sharma S Inflammopharmacology. 2023; 31(3):1279-1288.

PMID: 37038017 DOI: 10.1007/s10787-023-01219-8.

Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing.

Mehanna M, Chen Y, Gong Y, Handberg E, Roth B, de Leon J Clin Transl Sci. 2020; 14(2):617-624.

PMID: 33142006 PMC: 7993275. DOI: 10.1111/cts.12922.

General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation.

Yam M, Loh Y, Tan C, Adam S, Abdul Manan N, Basir R Int J Mol Sci. 2018; 19(8).

PMID: 30042373 PMC: 6121522. DOI: 10.3390/ijms19082164.

Mechanism of vasorelaxation induced by 3'-hydroxy-5,6,7,4'-tetramethoxyflavone in the rats aortic ring assay.

Tan C, Yam M Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(6):561-569.

PMID: 29552696 DOI: 10.1007/s00210-018-1481-9.

Overview of the Microenvironment of Vasculature in Vascular Tone Regulation.

Loh Y, Tan C, Chng Y, Yeap Z, Ng C, Yam M Int J Mol Sci. 2018; 19(1).

PMID: 29301280 PMC: 5796069. DOI: 10.3390/ijms19010120.

References

Frieden M, Sollini M, Beny J . Substance P and bradykinin activate different types of KCa currents to hyperpolarize cultured porcine coronary artery endothelial cells. J Physiol. 1999; 519 Pt 2:361-71. PMC: 2269517. DOI: 10.1111/j.1469-7793.1999.0361m.x. View

Weir M, Dzau V . The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens. 2000; 12(12 Pt 3):205S-213S. DOI: 10.1016/s0895-7061(99)00103-x. View

Walch L, Gascard J, Dulmet E, Brink C, Norel X . Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol. 2000; 130(1):73-8. PMC: 1572048. DOI: 10.1038/sj.bjp.0703301. View

Chen J, Yildiz O, Purdy R . Phenylephrine precontraction increases the sensitivity of rabbit femoral artery to serotonin by enabling 5-HT1-like receptors. J Cardiovasc Pharmacol. 2000; 35(6):863-70. DOI: 10.1097/00005344-200006000-00006. View

Smith W, Dewitt D, Garavito R . Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000; 69:145-82. DOI: 10.1146/annurev.biochem.69.1.145. View

de Gasparo M, Catt K, Inagami T, Wright J, Unger T . International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000; 52(3):415-72. View

Dannhardt G, Kiefer W . Cyclooxygenase inhibitors--current status and future prospects. Eur J Med Chem. 2001; 36(2):109-26. DOI: 10.1016/s0223-5234(01)01197-7. View

Adding L, Bannenberg G, Gustafsson L . Basic experimental studies and clinical aspects of gadolinium salts and chelates. Cardiovasc Drug Rev. 2001; 19(1):41-56. DOI: 10.1111/j.1527-3466.2001.tb00182.x. View

Schumacher M, Rivard A, Bachinger H, Adelman J . Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature. 2001; 410(6832):1120-4. DOI: 10.1038/35074145. View

10.

Prakriya M, Lewis R . Potentiation and inhibition of Ca(2+) release-activated Ca(2+) channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors. J Physiol. 2001; 536(Pt 1):3-19. PMC: 2278849. DOI: 10.1111/j.1469-7793.2001.t01-1-00003.x. View

11.

Ma H, Venkatachalam K, Parys J, Gill D . Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes. J Biol Chem. 2001; 277(9):6915-22. DOI: 10.1074/jbc.M107755200. View

12.

Leemhuis J, Boutillier S, Schmidt G, Meyer D . The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase. J Pharmacol Exp Ther. 2002; 300(3):1000-7. DOI: 10.1124/jpet.300.3.1000. View

13.

Burnham M, Bychkov R, Feletou M, Richards G, Vanhoutte P, Weston A . Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol. 2002; 135(5):1133-43. PMC: 1573217. DOI: 10.1038/sj.bjp.0704551. View

14.

Fellner S, Arendshorst W . Store-operated Ca2+ entry is exaggerated in fresh preglomerular vascular smooth muscle cells of SHR. Kidney Int. 2002; 61(6):2132-41. DOI: 10.1046/j.1523-1755.2002.00383.x. View

15.

Bootman M, Collins T, MacKenzie L, Roderick H, Berridge M, Peppiatt C . 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J. 2002; 16(10):1145-50. DOI: 10.1096/fj.02-0037rev. View

16.

Bychkov R, Burnham M, Richards G, Edwards G, Weston A, Feletou M . Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol. 2002; 137(8):1346-54. PMC: 1573623. DOI: 10.1038/sj.bjp.0705057. View

17.

Bouschet T, Perez V, Fernandez C, Bockaert J, Eychene A, Journot L . Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cells. J Biol Chem. 2002; 278(7):4778-85. DOI: 10.1074/jbc.M204652200. View

18.

Lenfant C, Chobanian A, Jones D, Roccella E . Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension. 2003; 41(6):1178-9. DOI: 10.1161/01.HYP.0000075790.33892.AE. View

19.

Taylor M, Bonev A, Gross T, Eckman D, Brayden J, Bond C . Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res. 2003; 93(2):124-31. DOI: 10.1161/01.RES.0000081980.63146.69. View

20.

Chandy K, Wulff H, Beeton C, Pennington M, Gutman G, Cahalan M . K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci. 2004; 25(5):280-9. PMC: 2749963. DOI: 10.1016/j.tips.2004.03.010. View